-
21:00
-
13:30
-
11:45
-
18:00
-
15:31
-
10:45
-
18:30
-
18:00
-
13:30
Keywords: NOVO NORDISK
France is set to begin reimbursing weight-loss medications for severely obese patients starting in mid-June, according to Health Minister Stéphanie Rist. The decision marks a significant step in the country’s public health strategy to address rising obesity rates and improve access to modern......
The Eli Lilly and Co weight-loss pill has received approval from the U.S. Food and Drug Administration, marking a major step in the growing market for oral obesity treatments. The drug, called orforglipron and marketed under the brand name Foundayo, becomes the second pill-based option available in the......
Marrakesh, November 4, 2025 — The pharmaceutical company Novo Nordisk, in partnership with Laprophan Laboratories, has officially launched Semaglutide in Morocco — an innovative medication designed for patients with type 2 diabetes. The announcement was made......
Morocco ranks among the top 10 countries with the highest prevalence of type 1 diabetes in children, with over 43,000 cases reported in individuals under the age of 19. In a significant step to address this pressing health issue, Danish pharmaceutical company Novo Nordisk and the Moroccan Society for......